The Company
48 Hour Discovery Inc.(48HD) has a powerful new technology platform for peptide-based
drug discovery. Our technology can discover drug leads in days rather than months.
We accelerate discovery to find new and better drugs in massively high-throughput screens
based on DNA-encoded molecular libraries and proprietary algorithms. Our patented
technology, which combines phage display and next generation sequencing, can screen
billions of unique peptides within weeks.
We provide peptide-based drug discovery services for global pharmaceutical companies
and also utilize the platform for internal discovery programs. The global peptide
therapeutics market was valued at $28.5 billion (USD) in 2021 and is expected to grow at a
CAGR of 9.66% over the forecast period. (Research and Markets 2021).
Our unique platform enables the rapid identification of both standard and macrocyclic
peptides, which exhibit excellent potency, selectivity, and GI stability for oral delivery. In
addition, our technology is well suited for cell based targets, an area of drug discovery that
has traditionally been challenging for peptides and antibodies.
The Product Platform
Using our platform technology, we rapidly sort through libraries containing billions of peptides, to find the best candidates, data, and information for targeted drug development. We provide open data accessibility for researchers in academia and industry that other platform competitors do not provide.
Service: Contracts with clients from pharma, research, academia, and startups
Product: Provision of Cloud + Libraries to other discovery ventures
Platform: Ongoing discussion of limited use license of our technology to research centers and pharmaceutical companies.
Competitive Advantage Through Science
Current drug model:
Discover from 1 billion random points with High Throughput Screening, then optimize.
$500K-$1M and 6-12 months of time.
48 Hour Discovery Model:
Discover from 1 billion optimal
starting points.
Only $50K and 1 week through our platform
Our patented linker leads to 1B optimal starting points that could be up to 10x more stable than some of our leading competitors.
Competitive Advantage Through Information Technology
Browse data of 2,000,000 ligands from 10,000+ screens
Our technology allows data search, cloud visualization, and analysis of user curated content that is open and secure to access.
The informatics and algorithms of our platform make our panning processes more effective and rapid than those of our competitors so customers can make better informed decisions.
